Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma.
Buckley AM, Lynam-Lennon N, Kennedy SA, Dunne MR, Aird JJ, Foley EK, Clarke N, Ravi N, O'Toole D, Reynolds JV, Kennedy BN, O'Sullivan J.
Buckley AM, et al.
Oncotarget. 2018 Sep 14;9(72):33634-33647. doi: 10.18632/oncotarget.25950. eCollection 2018 Sep 14.
Oncotarget. 2018.
PMID: 30263091
Free PMC article.